All In Biotech

Free tool

FAERS Monitor: Marcaine

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018692 or its brand name (Marcaine, Bupivacaine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

4,689

Serious

2,689

57% of reports

Hospitalization

1,124

Death reported

313

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,616
  • anaesthetic complication283
  • off label use246
  • pain219
  • hypoaesthesia209
  • maternal exposure during pregnancy209
  • hypotension199
  • headache177
  • dyspnoea168
  • dizziness154
  • nausea145
  • condition aggravated143
  • fatigue142
  • hypertension142
  • vomiting133

Reports by year received

View as table
YearReports
200491
200577
200697
200765
200880
2009115
201086
2011100
201292
201398
2014122
2015191
2016617
2017385
2018244
2019240
2020239
2021194
2022401
2023251
2024325
2025333
2026246

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,470 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
anaesthetic complicationSignal283528.2468.6132,793
maternal exposure during pregnancySignal20910.59.21,799
hypoaesthesiaSignal2096.35.5926
drug ineffectiveSignal1,6165.55.36,344
hypotensionSignal1994.53.9534
hypertensionSignal1423.02.6190
condition aggravatedSignal1432.11.884
pain2191.61.450
dizziness1541.41.216
dyspnoea1681.31.114
vomiting1331.31.17
headache1771.31.110
off label use2461.31.114
nausea1450.80.76
fatigue1420.80.76

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.